Abstract

Medical research shows that eye movement disorders are related to many kinds of neurological diseases. Eye movement characteristics can be used as biomarkers of Parkinson’s disease, Alzheimer’s disease (AD), schizophrenia, and other diseases. However, due to the unknown medical mechanism of some diseases, it is difficult to establish an intuitive correspondence between eye movement characteristics and diseases. In this paper, we propose a disease classification method based on decision tree and random forest (RF). First, a variety of experimental schemes are designed to obtain eye movement images, and information such as pupil position and area is extracted as original features. Second, with the original features as training samples, the long short-term memory (LSTM) network is used to build classifiers, and the classification results of the samples are regarded as the evolutionary features. After that, multiple decision trees are built according to the C4.5 rules based on the evolutionary features. Finally, a RF is constructed with these decision trees, and the results of disease classification are determined by voting. Experiments show that the RF method has good robustness and its classification accuracy is significantly better than the performance of previous classifiers. This study shows that the application of advanced artificial intelligence (AI) technology in the pathological analysis of eye movement has obvious advantages and good prospects.

Highlights

  • Eye movement information can be used as an important indicator of a variety of medical diseases and has been a focus of extensive research

  • They analyzed the relationship between the children’s eye gaze performance and social communication outcome measures that are typically used in autism spectrum disorder (ASD) clinical trials, and it was proposed that eye gaze tracking could be a non-invasive, quantitative, and objective biomarker associated with social communication abilities in children with ASD

  • Malsert et al (2012) carried out an experiment in which patients with major depressive disorder (MDD) performed an antisaccade task, and the results suggested that antisaccade performance is associated with the clinical scale score

Read more

Summary

Introduction

Eye movement information can be used as an important indicator of a variety of medical diseases and has been a focus of extensive research. Murias et al (2018) carried out an eye gaze tracking experiment in which children with autism spectrum disorder (ASD), aged 24–72, months were asked to watch a videotape that was designed to attract the attention of children to evaluate their social communication skills. They analyzed the relationship between the children’s eye gaze performance and social communication outcome measures that are typically used in ASD clinical trials, and it was proposed that eye gaze tracking could be a non-invasive, quantitative, and objective biomarker associated with social communication abilities in children with ASD. It was found that pupil dilation features are related to individual differences measured by the Social Responsiveness Scale, a measurement for autism traits

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call